Patrys Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Patrys.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth	15.3%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Nov 08

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

Mar 24

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Nov 09

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Patrys has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

ASX:PAB - Analysts future estimates and past financials data (AUD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2024	1	-4	-2	-2	N/A
3/31/2024	2	-4	-2	-2	N/A
12/31/2023	2	-5	-1	-1	N/A
9/30/2023	2	-6	-4	-4	N/A
6/30/2023	3	-7	-6	-6	N/A
3/31/2023	3	-7	-6	-6	N/A
12/31/2022	4	-6	-7	-7	N/A
9/30/2022	3	-6	-8	-8	N/A
6/30/2022	3	-7	-9	-9	N/A
3/31/2022	3	-7	-8	-8	N/A
12/31/2021	3	-7	-8	-8	N/A
9/30/2021	2	-5	-6	-6	N/A
6/30/2021	1	-4	-4	-4	N/A
3/31/2021	1	-4	-4	-4	N/A
12/31/2020	1	-3	-3	-3	N/A
9/30/2020	1	-3	-3	-3	N/A
6/30/2020	1	-3	-2	-2	N/A
3/31/2020	1	-3	-2	-2	N/A
12/31/2019	1	-3	-2	-2	N/A
9/30/2019	1	-2	-1	-1	N/A
6/30/2019	1	0	0	0	N/A
3/31/2019	1	-1	0	0	N/A
12/31/2018	1	-1	0	0	N/A
9/30/2018	1	-2	-1	-1	N/A
6/30/2018	1	-2	-2	-2	N/A
3/31/2018	0	-2	N/A	-2	N/A
12/31/2017	0	-2	N/A	-2	N/A
9/30/2017	0	-1	N/A	-2	N/A
6/30/2017	1	-1	N/A	-1	N/A
3/31/2017	1	-1	N/A	-1	N/A
12/31/2016	1	-1	N/A	-1	N/A
9/30/2016	1	-1	N/A	-1	N/A
6/30/2016	1	-1	N/A	-2	N/A
3/31/2016	1	-4	N/A	-2	N/A
12/31/2015	2	-6	N/A	-2	N/A
9/30/2015	2	-7	N/A	-3	N/A
6/30/2015	2	-8	N/A	-4	N/A
3/31/2015	2	-8	N/A	-5	N/A
12/31/2014	1	-7	N/A	-7	N/A
9/30/2014	1	-7	N/A	-6	N/A
6/30/2014	1	-7	N/A	-5	N/A
3/31/2014	1	-6	N/A	-4	N/A
12/31/2013	1	-6	N/A	-3	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if PAB's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if PAB's earnings are forecast to grow faster than the Australian market

High Growth Earnings: Insufficient data to determine if PAB's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if PAB's revenue is forecast to grow faster than the Australian market.

High Growth Revenue: Insufficient data to determine if PAB's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if PAB's Return on Equity is forecast to be high in 3 years time

Patrys Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Patrys Limited, Annual General Meeting, Nov 22, 2024

Full year 2024 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2023)

New major risk - Market cap size

New major risk - Share price stability

New major risk - Market cap size

New major risk - Market cap size

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Patrys Limited Announces Retirement of Suzy Jones as Director

Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2022)

Patrys Limited, Annual General Meeting, Nov 15, 2023

New minor risk - Financial data availability

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)

Patrys Limited Appoints Charmaine Gittleson as the Chairman of the Board of Directors, Effective November 16, 2022

No independent directors

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Patrys Limited Announces New Preclinical Data for its Full-Sized IgG Antibody, Pat-DX3

Patrys Limited, Melbourne Ordinary Shares to Be Deleted from OTC Equity

Will Patrys (ASX:PAB) Spend Its Cash Wisely?

Patrys Limited Announces Appointment of Mr. Stefan Ross as Non-Executive Director

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2021)

Patrys Limited Announces Update on PAT-DX1 From Engineering Run Meets all Specification Tests

Patrys Limited Announces New Pre-Clinical Data for Its Lead Asset, Pat-Dx1

Patrys Limited Announces Successful Completion of Pat-Dx1 Engineering Run

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

No independent directors

We're Not Very Worried About Patrys' (ASX:PAB) Cash Burn Rate

MD, CEO & Executive Director exercised options to buy AU$360k worth of stock.

Full year 2021 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2020)

Patrys Limited Provides This Interim Update on Its PAT-DX1 Clinical Trial Program

Patrys Limited Announces Full Size Deoxymab PAT-DX3 Able to Cross the Blood Brain Barrier

Patrys Limited Announces the Publication of New Preclinical Data for Its Deoxymab Antibody PAT-DX1

We're Hopeful That Patrys (ASX:PAB) Will Use Its Cash Wisely

Companies Like Patrys (ASX:PAB) Are In A Position To Invest In Growth

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2020)

Patrys Limited Successfully Establishes PAT-DX1 Stable Cell Line

What Can We Make Of Patrys' (ASX:PAB) CEO Compensation?

Patrys Limited Adds Full Human Antibody to Deoxymab Portfolio

Earnings released

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies